Association study between the -62A/T NFKBIL1 polymorphism and obsessive-compulsive disorder

Area of Science:

• Genetics
• Psychiatry
• Immunology

Background:

• Immunologic mechanisms are implicated in obsessive-compulsive disorder (OCD) pathophysiology.
• The nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1 (NFKBIL1) gene modulates the immune system.
• Investigating genetic variations in NFKBIL1 may reveal risk factors for OCD.

Purpose of the Study:

• To examine the association between the NFKBIL1 gene -62A/T polymorphism (rs2071592) and obsessive-compulsive disorder (OCD).
• To assess the -62A/T NFKBIL1 polymorphism as a potential genetic risk factor for OCD development.

Main Methods:

• A case-control study was conducted.
• Genotyping of the NFKBIL1 -62A/T polymorphism was performed.
• The study included 111 OCD patients and 272 healthy controls matched for age and gender.

Main Results:

• No significant differences in genotypic distributions were observed between OCD patients and healthy controls.
• The chi-squared test yielded a p-value of 0.61, indicating no statistical association.

Conclusions:

• The -62A/T NFKBIL1 polymorphism is not associated with obsessive-compulsive disorder in the studied Brazilian sample.
• Further investigation with broader polymorphism coverage in NFKBIL1 is needed.
• Future studies should include diverse ethnic populations to explore potential genetic links to OCD.